As of 2025-05-22, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (51,825.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -16374558.7%.
The range of the Relative Valuation is (40,727.94) - (66,354.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 14.5x | 10.6x |
| Forward P/E multiples | 8.9x - 15.1x | 12.0x |
| Fair Price | (40,727.94) - (66,354.51) | (51,825.16) |
| Upside | -12868328.0% - -20965190.6% | -16374558.7% |
| Date | P/E |
| 2025-05-13 | -0.00 |
| 2025-05-12 | -0.00 |
| 2025-05-02 | -0.00 |
| 2025-04-29 | -0.00 |
| 2025-04-28 | -0.00 |
| 2025-04-25 | -0.00 |
| 2025-04-24 | -0.00 |
| 2025-04-23 | -0.00 |
| 2025-04-22 | -0.00 |
| 2025-04-21 | -0.00 |
| 2025-04-16 | -0.00 |
| 2025-04-09 | -0.00 |
| 2025-04-08 | -0.00 |
| 2025-04-04 | -0.00 |
| 2025-04-03 | -0.00 |
| 2025-04-01 | -0.00 |
| 2025-03-31 | -0.00 |
| 2025-03-26 | -0.00 |
| 2025-03-24 | -0.00 |
| 2025-03-19 | -0.00 |
| 2025-03-18 | -0.00 |
| 2025-03-17 | -0.00 |
| 2025-03-13 | -0.00 |
| 2025-03-11 | -0.00 |
| 2025-03-10 | -0.00 |
| 2025-03-07 | -0.00 |
| 2025-03-06 | -0.00 |
| 2025-03-05 | -0.00 |
| 2025-02-26 | -0.00 |
| 2025-02-24 | -0.00 |
| 2025-02-20 | -0.00 |